Ignite Creation Date:
2024-05-05 @ 10:40 PM
Last Modification Date:
2024-10-26 @ 10:22 AM
Study NCT ID:
NCT01160445
Status:
TERMINATED
Last Update Posted:
2015-10-28
First Post:
2010-07-09
Brief Title:
Phase II Study of Aldesleukin IL-2 Following the Administration of Zanolimumab Anti-CD4mAb in Metastatic Melanoma and Metastatic Renal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2012-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-09
First Submit QC Date:
July 9 2010
Study First Post Date:
2010-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-12-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-06
Last Update Post Date:
2015-10-28
Last Update Post Date Type:
ESTIMATED